1 Min Read
Aug 10 (Reuters) - Madrigal Pharmaceuticals Inc:
* Madrigal Pharmaceuticals reports 2017 second quarter financial results
* Qtrly loss per share $0.69 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.